Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lusher

Showing results (31-40 of 177) with videos related to

Pageof 18
Sort By:
Seminars in Hematology|July 1, 1991
Thrombogenicity associated with factor IX complex concentratesJ M Lusher
Scandinavian Journal of Haematology. Supplementum|January 1, 1984
The role of prothrombin complex concentrates in the treatment of hemophiliacs with factor VIII inhibitorsJ M Lusher
Annals of Hematology|January 1, 1994
Summary of clinical experience with recombinant factor VIII products--KogenateJ M Lusher
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Recombinant factor VIIa: a viewpoint by Jeanne M. LusherJ M Lusher
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2012
Development and introduction of recombinant factor VIII--a clinician's experienceJ M Lusher
Blood|January 18, 2014
A longer acting rFVIII, safe and effectiveJeanne M Lusher
The New England Journal of Medicine|February 16, 1984
Myocardial necrosis after therapy with prothrombin-complex concentrateJ M Lusher
Seminars in Hematology|April 1, 1993
Prediction and management of adverse events associated with the use of factor IX complex concentratesJ M Lusher
Seminars in Hematology|April 1, 1994
Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors--benefits and limitationsJ M Lusher
Transfusion|October 1, 1993
Hemophilia: continued challenges but reason for optimism on many frontsJ M Lusher
Pageof 18

Showing results (31-40 of 177) with videos related to

Sort By:
Pageof 18
Seminars in Hematology|July 1, 1991
Thrombogenicity associated with factor IX complex concentratesJ M Lusher
Scandinavian Journal of Haematology. Supplementum|January 1, 1984
The role of prothrombin complex concentrates in the treatment of hemophiliacs with factor VIII inhibitorsJ M Lusher
Annals of Hematology|January 1, 1994
Summary of clinical experience with recombinant factor VIII products--KogenateJ M Lusher
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Recombinant factor VIIa: a viewpoint by Jeanne M. LusherJ M Lusher
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2012
Development and introduction of recombinant factor VIII--a clinician's experienceJ M Lusher
Blood|January 18, 2014
A longer acting rFVIII, safe and effectiveJeanne M Lusher
The New England Journal of Medicine|February 16, 1984
Myocardial necrosis after therapy with prothrombin-complex concentrateJ M Lusher
Seminars in Hematology|April 1, 1993
Prediction and management of adverse events associated with the use of factor IX complex concentratesJ M Lusher
Seminars in Hematology|April 1, 1994
Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors--benefits and limitationsJ M Lusher
Transfusion|October 1, 1993
Hemophilia: continued challenges but reason for optimism on many frontsJ M Lusher
Pageof 18